所有接受大量输血的患者都应同等对待吗?非创伤情况下大量输血比例分析
本研究为一项前瞻性观察性队列的回顾性分析,纳入2011至2015年某三级医疗中心接受大量输血的外科和重症非创伤患者共601例,最常见指征为心胸外科手术和胃肠道或肝胰胆道出血。主要终点为30天死亡率。结果显示,新鲜冰冻血浆与浓缩红细胞比例高于1:2与30天死亡率增加无关;血小板与浓缩红细胞比例高于1:2与48小时死亡率降低相关(10.5% vs 19.3%;p=0.032),但与30天死亡率无关。控制基线特征和疾病严重程度后,血浆及血小板与红细胞比例均与30天死亡率风险比无关。作者认为,创伤患者试验中高比例输血的获益在非创伤大量输血人群中未观察到,大于1:2的比例输血可能并非适用于所有大量出血患者,需进一步研究指导非创伤患者的复苏策略。
要点
- 在601例非创伤大量输血患者中,血小板与浓缩红细胞比例高于1:2与48小时死亡率降低相关(10.5% vs 19.3%;p=0.032),但与30天死亡率无关。
- 新鲜冰冻血浆与浓缩红细胞比例高于1:2与30天死亡率增加无关。
- 控制基线特征和疾病严重程度后,新鲜冰冻血浆及血小板与浓缩红细胞比例均与30天死亡率风险比无关。
- 非创伤大量输血最常见的指征为心胸外科手术和胃肠道或肝胰胆道出血。
- 作者认为,大于1:2的比例输血可能并非适用于所有大量出血患者,需进一步研究指导非创伤患者的复苏策略。
适用人群与场景
- 2011至2015年某三级医疗中心接受大量输血的外科和重症非创伤患者。
研究设计与关键结果
- 研究类型:前瞻性观察性队列的回顾性分析;样本量:601例非创伤大量输血患者;人群:外科和重症非创伤患者;干预与对照:按血浆、血小板和红细胞输血比例分为高比例组和低比例组;主要终点:30天死亡率,新鲜冰冻血浆与浓缩红细胞比例高于1:2与30天死亡率增加无关,控制基线特征和疾病严重程度后与30天死亡率风险比无关;关键次要终点:48小时死亡率,血小板与浓缩红细胞比例高于1:2与48小时死亡率降低相关(10.5% vs 19.3%;p=0.032),但与30天死亡率无关;其他次要终点:住院时间、ICU时间、无呼吸机天数。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列的回顾性分析;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,创伤患者试验中高比例新鲜冰冻血浆与浓缩红细胞及血小板与浓缩红细胞输血的获益在非创伤大量输血人群中未观察到,大于1:2的比例输血可能并非适用于所有大量出血患者,需进一步研究指导非创伤患者的复苏策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although balanced resuscitation has become integrated into massive transfusion practice, there is a paucity of evidence supporting the delivery of high ratios of plasma and platelet to RBCs in the nontrauma setting. This study investigated the administration of blood component ratios in the massively transfused nontrauma demographic.
DESIGN: Retrospective analysis of a prospective, observational cohort of massively bleeding patients.
SETTING: Surgical and critically ill patients at a tertiary medical center between 2011 and 2015.
PATIENTS: Massively transfused nontrauma patients.
INTERVENTIONS: Patients receiving plasma, platelet, and RBC transfusions were categorized into high and low ratio groups and analyzed for differences in characteristics and clinical outcomes.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was 30-day mortality. Secondary outcomes included 48-hour mortality, hospital length of stay, ICU length of stay, and ventilator-free days. Among 601 massively transfused nontrauma patients, cardiothoracic surgery and gastrointestinal or hepato-pancreatico-biliary bleeds were the most common indications for massive transfusion. Higher fresh frozen plasma ratios (> 1:2) were not associated with increased 30-day mortality. A high platelets-to-packed RBCs ratio (> 1:2) was associated with decreased 48-hour mortality (10.5% vs 19.3%; p = 0.032), but not 30-day mortality. Fresh frozen plasma-to-packed RBCs and platelets-to-packed RBCs ratios were not associated with 30-day mortality hazard ratios after controlling for baseline characteristics and disease severity.
CONCLUSIONS: The benefits of higher ratios of fresh frozen plasma-to-packed RBCs and platelets-to-packed RBCs described in trials of trauma patients were not observed in this analysis of a nontrauma, massively transfused population. These data suggest that greater than 1:2 ratio transfusion in the setting of massive hemorrhage may not be appropriate for all patients, and that further research to guide appropriate resuscitation strategies in nontrauma patients is warranted.
参考来源
- Etchill EW, Myers SP, McDaniel LM, et al. Should All Massively Transfused Patients Be Treated Equally? An Analysis of Massive Transfusion Ratios in the Nontrauma Setting. Crit Care Med. 2017. PMID: 28537938. doi:10.1097/CCM.0000000000002498
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。